Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Exova wins long term agreement

29 Jul 2015 11:00

RNS Number : 3570U
Exova Group PLC
29 July 2015
 

 

 

 

29 July 2015

 

 

Exova wins long term agreement with The Ulven Companies

 

Exova, the global testing group, has signed a three-year long term agreement with The Ulven Companies to provide mechanical, chemical and metallography testing services. The new contract extends a relationship spanning more than nine years.

 

The agreement will see Exova deliver a programme of fatigue, creep and thermal testing of wrought aerospace-grade alloys and support The Ulven Companies to develop future technologies to meet growing market demand from manufacturers. The work will be conducted at the company's specialist materials testing laboratory in Portland, Oregon, USA.

 

The Ulven Companies is one of the world's leading providers of metal forging and foundry services for applications in sectors including aerospace, military, oil & gas and infrastructure.

 

Dan Ulven, President of the Ulven Companies, said: "We are pleased to have entered into this long term agreement with Exova. Our customers span across multiple industries, each with their unique certifications and standards. The variety of standards and custom specifications presented to us is a challenge for most companies to address. I believe that Exova is uniquely positioned to take on these certification challenges, and with this agreement in place, I know that I can count on Exova to meet our evolving testing needs."

 

Rocco J. Moro, Vice President of Aerospace for Exova in the Americas said: "This new long term agreement further underlines Exova's reputation at the forefront of metallurgical testing. Our team in Portland draw on our global expertise to support Ulven's advancement of specialty forgings along with the steel castings manufactured by Wolf Steel Foundry."

 

 

 

 

 

 

All media enquiries, please contact:

 

Stuart Neill, Group Communications Manager, Exova

Tel. +44 131 335 4371 / +44 7799 365 043

E: stuart.neill@exova.com

 

Angela Casey

Pagoda Porter Novelli

T: +44 131 556 0770

E: angela.casey@pagodapr.com

 

Exova

 

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 143 laboratories and offices in 32 countries and employs around 4,400 people throughout Europe, the Americas, the Middle East and Asia/Asia Pacific.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors from health sciences to aerospace, transportation, oil and gas, fire and construction.

Exova in Aerospace

In aerospace, Exova supports commercial and military primes and their global supply chains via a network of 13 Nadcap approved laboratories worldwide (more than any other independent testing group). It also holds approvals from all major OEMs. It specialises in the provision of mechanicalnon-destructive and chemical testing programmes for aerospace composites, alloys and ceramics.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAQVLFLEDFBBBV
Date   Source Headline
29th Jun 201711:22 amRNSForm 8.5 (EPT/RI)
29th Jun 201710:41 amRNSScheme of Arrangement becomes effective
28th Jun 20174:53 pmRNSTR1: Notification of Major Interest in Shares
28th Jun 20173:30 pmRNSForm 8.3 - EXO LN
28th Jun 20172:52 pmRNSForm 8.5 (EPT/RI)
28th Jun 20172:27 pmBUSForm 8.3 - Exova Group Plc
28th Jun 20171:45 pmRNSForm 8.3 - [Exova Group Plc]
28th Jun 20171:25 pmRNSForm 8.3 - Exova Group PLC
28th Jun 201712:11 pmRNSCourt Approval of Scheme
28th Jun 201711:17 amRNSForm 8.3 - Exova Group Plc
27th Jun 20176:00 pmRNSSuspension - Exova Group PLC
27th Jun 20173:30 pmRNSForm 8.3 - EXO LN
27th Jun 20173:09 pmRNSForm 8.3 - Exova Group Plc
27th Jun 20171:51 pmRNSTR-1: Notification of Major Interest in Shares
27th Jun 20171:40 pmRNSForm 8.3 - EXOVA GROUP PLC
27th Jun 201710:26 amRNSTR-1: Notification of Major Interest in Shares
27th Jun 20179:38 amRNSForm 8.3 - Exova Group Plc
27th Jun 20179:34 amRNSForm 8.3 - Exova Group Plc
26th Jun 20174:50 pmRNSDirectorate Change
26th Jun 20174:20 pmRNSForm 8.3 - Exova Group Plc
26th Jun 20173:30 pmRNSForm 8.3 - EXO LN
26th Jun 20172:46 pmBUSForm 8.3 - Exova Group plc
26th Jun 201710:36 amRNSForm 8.5 (EPT/RI)
26th Jun 201710:31 amRNSSuspension of trading of Exova Shares
26th Jun 201710:16 amRNSForm 8.5 (EPT/RI)
23rd Jun 20173:01 pmRNSForm 8.3 - Exova Group Plc
22nd Jun 201711:00 amRNSForm 8.5 (EPT/RI)
22nd Jun 20179:57 amRNSForm 8.5 (EPT/RI)
21st Jun 20172:26 pmRNSForm 8.5 (EPT/RI)
20th Jun 201711:07 amRNSForm 8.5 (EPT/RI)
20th Jun 201710:10 amRNSForm 8.3 - EXOVA PLC
19th Jun 20171:51 pmRNSForm 8.3 - Exova Group Plc
19th Jun 201710:45 amRNSForm 8.5 (EPT/RI)
16th Jun 201712:20 pmRNSForm 8.3 - Exova Group Plc
16th Jun 201711:08 amRNSForm 8.5 (EPT/RI)
16th Jun 20179:48 amRNSForm 8.3 - Exova Group PLC
15th Jun 20173:17 pmRNSForm 8.3 - Exova Group Plc
15th Jun 20173:08 pmRNSForm 8.5 (EPT/RI) - Amendment
15th Jun 20172:55 pmRNSTR-1: Notification of Major Interest in Shares
15th Jun 20171:54 pmRNSForm 8.3 - Exova Group Plc
15th Jun 201711:18 amRNSForm 8.5 (EPT/RI)
15th Jun 20179:52 amRNSForm 8.3 - EXOVA GROUP PLC
14th Jun 20173:30 pmRNSForm 8.3 - EXO LN
14th Jun 201712:14 pmRNSForm 8.3 - EXOVA GROUP PLC
14th Jun 201710:38 amRNSForm 8.5 (EPT/RI)
13th Jun 20174:09 pmRNSTR-1: Notification of Major Interest in Shares
13th Jun 20173:30 pmRNSForm 8.3 - EXO LN
13th Jun 201711:28 amRNSForm 8.5 (EPT/RI)
13th Jun 20179:13 amRNSForm 8.3 - EXOVA GROUP PLC
12th Jun 20173:30 pmRNSForm 8.3 - EXO LN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.